 |
Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles |
|---|---|
| Trade Name | |
| Orphan Indication | Argininosuccinic Aciduria |
| EU Market Approval | EU |
| EU Designation Date | 2017-12-12 00:00:00 |
| Sponsor | PhaseRx Ireland, Ltd |
